Sharon Nachman

Summary

Affiliation: Stony Brook University
Country: USA

Publications

  1. ncbi Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth
    Sharon Nachman
    Department of Pediatrics, Stony Brook University, Health Sciences Center T 11, Stony Brook, NY 11794, USA
    Arch Pediatr Adolesc Med 166:528-35. 2012
  2. ncbi The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis
    Sharon Nachman
    Department of Pediatrics, Stony Brook University, Stony Brook, NY 11794 8111, USA
    Pediatrics 115:e488-94. 2005
  3. ncbi Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era
    Sharon A Nachman
    Department of Pediatrics, Stony Brook University Medical Center, Stony Brook, NY 11794 8111, USA
    Arch Pediatr Adolesc Med 163:164-71. 2009
  4. ncbi Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection
    Sharon Nachman
    Department of Pediatrics, State University of New York Health Science Center at Stony Brook, Stony Brook, New York 11794, USA
    Pediatrics 112:66-73. 2003
  5. ncbi Central nervous system Lyme disease
    Sharon A Nachman
    Stony Brook University, Department of Pediatrics, Stony Brook, NY 11794 8111, USA
    Semin Pediatr Infect Dis 14:123-30. 2003
  6. ncbi CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy
    Akihiko Saitoh
    Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA
    J Acquir Immune Defic Syndr 54:285-9. 2010
  7. ncbi Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children
    Rita J Jeremy
    Pediatric Clinical Research Center, Department of Pediatrics, School of Medicine, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0105, USA
    Pediatrics 115:380-7. 2005
  8. ncbi Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons
    Kenneth D Gadow
    Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY 11794, USA
    J Dev Behav Pediatr 33:456-68. 2012
  9. ncbi Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment
    Adriana Weinberg
    Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA
    J Acquir Immune Defic Syndr 52:17-24. 2009
  10. ncbi Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample
    Kenneth D Gadow
    Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY 11794 8790, USA
    J Dev Behav Pediatr 31:116-28. 2010

Detail Information

Publications32

  1. ncbi Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth
    Sharon Nachman
    Department of Pediatrics, Stony Brook University, Health Sciences Center T 11, Stony Brook, NY 11794, USA
    Arch Pediatr Adolesc Med 166:528-35. 2012
    ..To evaluate associations between human immunodeficiency virus (HIV) disease severity and psychiatric and functional outcomes in youth with perinatal HIV infection...
  2. ncbi The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis
    Sharon Nachman
    Department of Pediatrics, Stony Brook University, Stony Brook, NY 11794 8111, USA
    Pediatrics 115:e488-94. 2005
    ....
  3. ncbi Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era
    Sharon A Nachman
    Department of Pediatrics, Stony Brook University Medical Center, Stony Brook, NY 11794 8111, USA
    Arch Pediatr Adolesc Med 163:164-71. 2009
    ....
  4. ncbi Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection
    Sharon Nachman
    Department of Pediatrics, State University of New York Health Science Center at Stony Brook, Stony Brook, New York 11794, USA
    Pediatrics 112:66-73. 2003
    ..This study was conducted to evaluate the safety and immunogenicity of heptavalent PCV in infants with HIV infection...
  5. ncbi Central nervous system Lyme disease
    Sharon A Nachman
    Stony Brook University, Department of Pediatrics, Stony Brook, NY 11794 8111, USA
    Semin Pediatr Infect Dis 14:123-30. 2003
    ..The focus of this article is on the manifestations, diagnosis, and treatment of Lyme disease of the central nervous system...
  6. ncbi CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy
    Akihiko Saitoh
    Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA
    J Acquir Immune Defic Syndr 54:285-9. 2010
    ....
  7. ncbi Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children
    Rita J Jeremy
    Pediatric Clinical Research Center, Department of Pediatrics, School of Medicine, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0105, USA
    Pediatrics 115:380-7. 2005
    ..Neuropsychological functioning and its correlation with viral load were investigated for previously treated HIV-infected children who underwent a change in treatment regimen...
  8. ncbi Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons
    Kenneth D Gadow
    Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY 11794, USA
    J Dev Behav Pediatr 33:456-68. 2012
    ..Cross-sectional research indicates high rates of mental health concerns among youth with perinatal HIV infection (PHIV), but few studies have examined emerging psychiatric symptoms over time...
  9. ncbi Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment
    Adriana Weinberg
    Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA
    J Acquir Immune Defic Syndr 52:17-24. 2009
    ..We sought to identify the immunologic and virologic factors associated with a robust response to hepatitis A virus (HAV) vaccine in children on highly active antiretroviral treatment...
  10. ncbi Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample
    Kenneth D Gadow
    Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY 11794 8790, USA
    J Dev Behav Pediatr 31:116-28. 2010
    ..To compare the rates of psychopathology in youths perinatally infected with HIV (N = 319) with a comparison sample of peers (N = 256) either HIV-exposed or living in households with HIV-infected family members...
  11. ncbi A behavioral and cognitive profile of clinically stable HIV-infected children
    Molly L Nozyce
    Department of Pediatrics, Bronx Lebanon Hospital Center, Bronx, New York, USA
    Pediatrics 117:763-70. 2006
    ..The purpose of this research was to characterize behavioral and cognitive profiles of clinically and immunologically stable antiretroviral-experienced HIV-infected children...
  12. ncbi Lopinavir exposure with an increased dose during pregnancy
    Mark Mirochnick
    Department of Pediatrics, Boston University School of Medicine, and Infectious Disease Division, Children s Hospital Boston, Boston, MA 02118, USA
    J Acquir Immune Defic Syndr 49:485-91. 2008
    ..The goal of this study was to determine LPV exposure during the third trimester of pregnancy and 2 weeks postpartum with a higher LPV/RTV dose...
  13. ncbi CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children
    Akihiko Saitoh
    Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego, La Jolla, California 92093 0672, USA
    AIDS 21:2191-9. 2007
    ....
  14. ncbi Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children
    Adriana Weinberg
    Department of Pediatrics, University of Colorado Denver, Aurora, CO, USA
    J Acquir Immune Defic Syndr 55:189-96. 2010
    ..Live-attenuated influenza vaccine (LAIV) prevents more cases of influenza in immune-competent children than the trivalent inactivated vaccine (TIV). We compared the antibody responses to LAIV or TIV in HIV-infected children...
  15. ncbi Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1
    Paul Krogstad
    Department of Pediatrics, University of California Los Angeles School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    AIDS Res Hum Retroviruses 18:413-7. 2002
    ..Non-B subtypes should be considered in the management of HIV-1-infected pregnant women and children to optimize strategies to prevent and treat pediatric HIV-1 infection...
  16. ncbi The link between religion and HAART adherence in pediatric HIV patients
    James Park
    School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA
    AIDS Care 22:556-61. 2010
    ..As perinatally HIV-infected youth age into adulthood, future studies will be needed to explore the ongoing intimate relationship between a patient's religious views and their compliance to medical regimens...
  17. ncbi Moving beyond the clinic: nutritional intervention in a human immunodeficiency virus-infected pregnant population
    Cheryl Seifert
    Department of Pediatrics, Division of Infectious Diseases, University Hospital at Stony Brook, HSC T-11-031, Stony Brook, NY 11794, USA
    J Am Diet Assoc 106:1119-21. 2006
  18. ncbi Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection
    Russell B Van Dyke
    Department of Pediatrics, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Pediatrics 109:e61. 2002
    ..Little is known about the adherence of children to HAART. The objective of this study was to identify correlates of adherence to HAART and the relationship between adherence and study outcomes in a pediatric clinical trial...
  19. ncbi Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents
    Ram Yogev
    Department of Pediatrics, Northwestern University Medical School, Chicago, IL, USA
    Pediatr Infect Dis J 29:827-30. 2010
    ..Two studies in hydrocephalic children and adolescents were performed to assess the penetration of linezolid into cerebrospinal fluid and its relation to meningeal inflammation...
  20. ncbi Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy
    Sharon A Nachman
    Department of Pediatrics, State University of New York Health Science Center at Stony Brook, Stony Brook, NY 11794 8111, USA
    Arch Pediatr Adolesc Med 156:497-503. 2002
    ..Human immunodeficiency virus (HIV)-infected children often suffer from impaired growth. Highly active antiretroviral therapy (HAART) successfully reduces HIV 1 (HIV-1) RNA to 400 copies/mL or less in many children...
  21. ncbi Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022
    Jane Hitti
    University of Washington, Seattle, 98195, USA
    J Acquir Immune Defic Syndr 36:772-6. 2004
    ..To compare the safety of nelfinavir and nevirapine-based antiretroviral treatment in HIV-1-infected pregnant women...
  22. ncbi Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
    Sharon A Nachman
    Department of Pediatrics, State University of New York Health Science Center at Stony Brook, Stony Brook, NY 11794, USA
    Pediatr Infect Dis J 24:352-7. 2005
    ..Previous reports of the effect of highly active antiretroviral therapy (HAART) on the growth of HIV-infected children have been contradictory...
  23. ncbi Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
    Samir K Gupta
    Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    Clin Infect Dis 40:1559-85. 2005
  24. ncbi Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection
    Howard M Rosenblatt
    Allergy and Immunology Section, Texas Children s Hospital, Houston 77030, USA
    J Infect Dis 192:445-55. 2005
    ..At week 44 of HAART, the major immunological parameters in these HIV-1-infected children moved from baseline values to about halfway to two-thirds of the way toward the values in healthy, uninfected children...
  25. ncbi Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection
    Howard M Rosenblatt
    Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    J Allergy Clin Immunol 116:698-703. 2005
    ..HIV infection often impairs the immune response to childhood vaccines...
  26. ncbi Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy
    Adriana Weinberg
    Department of Pediatrics and Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA
    J Infect Dis 193:302-11. 2006
    ..We investigated the safety and immunogenicity of 2 doses of hepatitis A virus (HAV) vaccine followed by a booster dose in HIV-infected children receiving stable highly active antiretroviral therapy...
  27. ncbi Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    School of Medicine, University of Colorado and Children s Hospital, Denver, Colorado, USA
    Pediatrics 120:e1190-202. 2007
    ..Our goal was to evaluate the immunogenicity and safety of pertussis booster vaccination in children infected with HIV on highly active antiretroviral therapy (HAART)...
  28. ncbi Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    University of Colorado School of Medicine, Pediatric Infectious Disease, The Children s Hospital, Denver, CO 80218, USA
    Pediatr Infect Dis J 25:920-9. 2006
    ....
  29. ncbi Incidence of opportunistic and other infections in HIV-infected children in the HAART era
    Philimon Gona
    Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Mass, USA
    JAMA 296:292-300. 2006
    ....
  30. ncbi Use of complementary and alternative medicine by parents of children with HIV infection and asthma and well children
    Jocelyn Y Ang
    Division of Pediatric Infectious Diseases, Children's Medical Center, The State University of New York at Stony Brook, Stony Brook, New York, USA
    South Med J 98:869-75. 2005
    ..This may be related to their socioeconomic factors. A larger and more diverse study population may provide more information on factors contributing to CAM usage in chronically ill and well children...
  31. ncbi An evaluation of awareness: attitudes and beliefs of pregnant Nigerian women toward voluntary counseling and testing for HIV
    Kingsley C Okonkwo
    Division Infectious Diseases, Department of Pediatrics, Stony Brook University, Stony Brook, New York, USA
    AIDS Patient Care STDS 21:252-60. 2007
    ....
  32. ncbi Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection
    Courtney V Fletcher
    Pediatric AIDS Clinical Trials Group and the Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver 80262, USA
    Pharmacotherapy 24:453-9. 2004
    ..To evaluate and describe the parameters and characteristics of different drug regimens in children infected with human immunodeficiency virus (HIV)...